China Resources Pharma Unit Wins Approval For RMB 1 Billion Medium-Term Notes

China Resources Pharmaceutical Group (03320) said its non-wholly owned subsidiary, Yunnan Kunyao Group Co., Ltd., received a registration acceptance notice from the National Association of Financial Market Institutional Investors for a planned medium-term note issuance in China. The notice is valid for two years from the date of issue, and Kunyao Group may issue medium-term notes in tranches with a total principal amount of RMB 1 billion during that period, according to ETNet.